FI104424B - Menetelmä onkostatiini M -mutantin valmistamiseksi - Google Patents

Menetelmä onkostatiini M -mutantin valmistamiseksi Download PDF

Info

Publication number
FI104424B
FI104424B FI922612A FI922612A FI104424B FI 104424 B FI104424 B FI 104424B FI 922612 A FI922612 A FI 922612A FI 922612 A FI922612 A FI 922612A FI 104424 B FI104424 B FI 104424B
Authority
FI
Finland
Prior art keywords
oncostatin
amino acid
mutant
att
mutants
Prior art date
Application number
FI922612A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922612A (fi
FI922612A0 (fi
Inventor
Peter S Linsley
Jeffrey C Kallestad
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of FI922612A publication Critical patent/FI922612A/fi
Publication of FI922612A0 publication Critical patent/FI922612A0/fi
Application granted granted Critical
Publication of FI104424B publication Critical patent/FI104424B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FI922612A 1989-12-08 1992-06-05 Menetelmä onkostatiini M -mutantin valmistamiseksi FI104424B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US44775989A 1989-12-08 1989-12-08
US44775989 1989-12-08
US62386790A 1990-12-03 1990-12-03
US62386790 1990-12-03
US9007227 1990-12-07
PCT/US1990/007227 WO1991009057A1 (fr) 1989-12-08 1990-12-07 Nouvelles proteines a activite d'oncostatine m et procede de preparation

Publications (3)

Publication Number Publication Date
FI922612A FI922612A (fi) 1992-06-05
FI922612A0 FI922612A0 (fi) 1992-06-05
FI104424B true FI104424B (fi) 2000-01-31

Family

ID=27035080

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922612A FI104424B (fi) 1989-12-08 1992-06-05 Menetelmä onkostatiini M -mutantin valmistamiseksi

Country Status (17)

Country Link
EP (1) EP0504291B1 (fr)
JP (1) JPH05504134A (fr)
KR (1) KR920703636A (fr)
CN (1) CN1055389A (fr)
AT (1) ATE168117T1 (fr)
AU (1) AU651330B2 (fr)
CA (1) CA2070171A1 (fr)
DE (1) DE69032471T2 (fr)
DK (1) DK0504291T3 (fr)
ES (1) ES2120958T3 (fr)
FI (1) FI104424B (fr)
GR (1) GR3027654T3 (fr)
IL (1) IL96593A0 (fr)
NO (1) NO301769B1 (fr)
NZ (1) NZ236382A (fr)
PT (1) PT96134B (fr)
WO (1) WO1991009057A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783672A (en) 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
JPH09117288A (ja) * 1995-06-06 1997-05-06 Bristol Myers Squibb Co オンコスタチンｍ誘導造血
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
US20120308517A1 (en) 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases

Also Published As

Publication number Publication date
NO301769B1 (no) 1997-12-08
CN1055389A (zh) 1991-10-16
EP0504291A4 (en) 1992-10-28
NO922202D0 (no) 1992-06-04
EP0504291B1 (fr) 1998-07-08
NZ236382A (en) 1992-08-26
KR920703636A (ko) 1992-12-18
WO1991009057A1 (fr) 1991-06-27
PT96134B (pt) 1998-04-30
AU7036191A (en) 1991-07-18
JPH05504134A (ja) 1993-07-01
FI922612A (fi) 1992-06-05
FI922612A0 (fi) 1992-06-05
AU651330B2 (en) 1994-07-21
DE69032471T2 (de) 1999-03-04
ATE168117T1 (de) 1998-07-15
EP0504291A1 (fr) 1992-09-23
DK0504291T3 (da) 1998-11-30
IL96593A0 (en) 1991-09-16
ES2120958T3 (es) 1998-11-16
GR3027654T3 (en) 1998-11-30
NO922202L (no) 1992-06-04
PT96134A (pt) 1991-09-30
CA2070171A1 (fr) 1991-06-09
DE69032471D1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
US5258287A (en) DNA encoding and methods of production of insulin-like growth factor binding protein BP53
JP3117992B2 (ja) 血管内皮細胞成長因子の生産およびそれをコードするｄｎａ
AU646014B2 (en) Novel platelet-derived growth factor B chain analogs and method for homogeneous production thereof
GB2214185A (en) Proteins and methods for their production
US5115096A (en) Amphiregulin: a bifunctional growth modulating glycoprotein
CA2084514A1 (fr) Interferon-alpha o-glycosyle
AU8899298A (en) Lipocalin homologs
JPH02442A (ja) エリトロポエチンを発現するヒトｃＤＮＡのクローニング方法
HU211984A9 (en) Neuroglial derived neurothrophic factors
EP1428883A1 (fr) Facteurs stimulateurs des mégacaryocytes
JPH06133793A (ja) ミュレル管抑制物質様ポリペプチドおよびその製造方法
EP0281363B1 (fr) Régulateur de croissance lie aux plaquettes sanguines
US5618715A (en) Oncostatin M and novel compositions having anti-neoplastic activity
US5874536A (en) Proteins with Oncostatin M activity and process for their preparation
JPH03195496A (ja) 成長因子
FI104424B (fi) Menetelmä onkostatiini M -mutantin valmistamiseksi
JPH03164183A (ja) 脳由来の膜蛋白質発現系
US5451506A (en) Oncostatin M and novel compositions having anti-neoplastic activity
IE904732A1 (en) Novel proteins with oncostatin m activity and process for¹their preparation
KR960016305B1 (ko) 온코스타틴 m 및 항신생물 활성을 갖는 신규 조성물
AU2005244575B2 (en) Human Vascular Endothelial Growth Factor 2